Product Name:

Blk-pY187


Product Number:

ab-pk542

Price:

Regular price
$89.00
Regular price
Sale price
$89.00

Download Product PDF

Target Full Name: B lymphoid tyrosine kinase

Target Alias: P55-Blk

Product Type Specific: Protein kinase phosphosite-specific antibody

Antibody Code: PK541

Antibody Target Type: Phosphosite-specific

Antibody Phosphosite: Y187

Protein UniProt: P51451

Protein SigNET: P51451

Antibody Type: Polyclonal

Antibody Host Species: Rabbit

Antibody Immunogen Source: Human Blk sequence peptide Cat. No.: PE-04AIQ99

Antibody Immunogen Sequence: EGG(pY)YIS(bA)C

Antibody Immunogen Description: Corresponds to amino acid residues E184 to S190; In the SH2 domain. One of the two major in vivo phosphorylation sites in Blk.

Production Method: Corresponds to amino acid residues E184 to S190; In the SH2 domain. One of the two major in vivo phosphorylation sites in Blk.

Antibody Modification: Protein kinase phosphosite-specific antibody

Antibody Concentration: 0.15/1.0 mg/ml

Storage Buffer: Phosphate buffered saline pH 7.4, 0.05% Thimerasol

Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.

Product Use: Western blotting | Antibody microarray

Antibody Dilution Recommended: 2 µg/ml for immunoblotting

Antibody Potency: Medium-weak immunoreactivity of a target-sized protein by Western blotting in Jurkat cells.

Antibody Species Reactivity: Human

Antibody Positive Control: The observed molecular mass of the processed target protein on SDS-PAGE gels is reported to be around 55-60 kDa.

Antibody Specificity: Very high

Antibody Cross Reactivity: No significant cross-reactive proteins detected in phenylarsine oxide (PAO)+vanadate-treated HeLa cells, EGF-treated A431 cells and insulin-treated MCF7 cells, when these cells were homogenized in SDS-PAGE sample buffer.

Scientific Background: Blk is a protein-tyrosine kinase that is a member of the TK group of protein kinases in the Src family. It has been reported that Blk is expressed specifically in the B cell lineage and plays a role in signal transduction pathway that is restricted to B lymphoid cells. However, this kinase has low to reasonably high expression (e.g. skeletal muscle, kidney, thyroid, breast) in most tested human tissues except in the brain and spinal cord where it is poorly expressed. Orthologues of Blk are highly conserved in mammals and birds. Blk is inhibited by phosphorylation at Y501. Blk has been linked with the development of colorectal adenocarcinomas. Stimulation of resting B-lymphocytes with antibodies to surface immunoglobulin (sIgD or sIgM) induces activation of Blk.